Subtype
Hepatopancreatobiliary Carcinoma
CI-CAN-00002859Explore in graph →
1,361 active trials21 approved drugs69 evidence items
- NCIt
- C214986
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002859Explore in graph →
Clinical trials
5,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (646)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00501176 | Preoperative Stent Study | completed | N/A | 92 | Karolinska InstitutetOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT05434520 | Relieving the Bile Ducts Prior to Pancreatoduodenectomy | completed | — | 722 | Rigshospitalet, DenmarkOTHER | 1 | Jun 28, 2022 | clinicaltrials |
| NCT02929082 |
| Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer(FORCE) |
| completed |
| N/A |
| 97 |
| Assistance Publique - Hôpitaux de ParisOTHER |
| 1 |
| Jun 24, 2022 |
| clinicaltrials |
| NCT00247728 | PI-88 in Hepatocellular Carcinoma After Hepatectomy | completed | Phase 2 | 172 | Cellxpert Biotechnology Corp.INDUSTRY | 1 | Jun 23, 2022 | clinicaltrials |
| NCT05406089 | Effects of Antiviral Therapy on Patients With HBV-related HCC | completed | — | 494 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Jun 21, 2022 | clinicaltrials |
| NCT03174574 | Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.(TCOG) | completed | — | 3 | Mayo ClinicOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT02451553 | Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer | completed | Phase 1 | 41 | University of WashingtonOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT04341909 | Trainee Involvement in ERCP Risk Score(TIERS) | completed | — | 1,283 | Clinical Hospital ColentinaOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT02243384 | Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma | completed | N/A | 150 | ChenJianOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05402618 | Minimally Invasive Versus Open Surgery for PHC | completed | — | 783 | Renyi QinOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT03156582 | Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)(Impact AFP) | completed | — | 562 | University Hospital, GrenobleOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT00790218 | A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 19 | Can-Fite BioPharmaINDUSTRY | 1 | May 17, 2022 | clinicaltrials |
| NCT03323489 | Celiac Plexus Radio-Surgery for Pain Management | completed | N/A | 125 | Dr. Yaacov LawrenceOTHER_GOV | 4 | May 12, 2022 | clinicaltrials |
| NCT04303286 | The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma | completed | — | 200 | Tongji HospitalOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT04027556 | Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction | completed | N/A | 90 | Seoul National University HospitalOTHER | 1 | May 4, 2022 | clinicaltrials |
| NCT05355662 | Prognosis Analysis of Elderly Donor Liver in Liver Transplantation | completed | — | 11,569 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | May 2, 2022 | clinicaltrials |
| NCT04316078 | A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies | completed | N/A | 126 | Sheba Medical CenterOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
| NCT01929902 | Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery | completed | — | 20 | Wake Forest University Health SciencesOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT00605150 | HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC | completed | — | 11 | Wake Forest University Health SciencesOTHER | 0 | Apr 22, 2022 | clinicaltrials |
| NCT01666145 | Advanced Image Guidance Utilized in Liver Surgery | completed | N/A | 14 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT05068193 | A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers | completed | Phase 1 | 57 | Boryung Pharmaceutical Co., LtdINDUSTRY | 1 | Apr 20, 2022 | clinicaltrials |
| NCT02178709 | A Phase II Study of Neoadjuvant FOLFIRINOX | completed | Phase 2 | 48 | Indiana UniversityOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT02354898 | A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 1 | 60 | Sumitomo Pharma Co., Ltd.INDUSTRY | 1 | Apr 12, 2022 | clinicaltrials |
| NCT02358395 | A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 12 | Sumitomo Pharma Co., Ltd.INDUSTRY | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04767750 | Role of LncRNA H19 in The Regulation of IGF-1R Expression | completed | — | 101 | Mansoura UniversityOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT03147768 | Laser Tissue Welding - Distal Pancreatectomy Sealing Study(LTW) | completed | Phase 1 | 11 | Laser Tissue Welding, Inc.INDUSTRY | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04659005 | Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening | completed | N/A | 178 | Chinese University of Hong KongOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT03105921 | Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma | completed | N/A | 20 | Poitiers University HospitalOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT03693378 | A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups | completed | — | 1,349 | Immunovia, Inc.INDUSTRY | 5 | Mar 31, 2022 | clinicaltrials |
| NCT04903340 | Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy(PYR) | completed | — | 30 | University Hospital, BordeauxOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02906397 | Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 15 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT04611100 | Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma | completed | N/A | 70 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Mar 23, 2022 | clinicaltrials |
| NCT01340105 | Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation | completed | N/A | 93 | Chinese University of Hong KongOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT03259581 | Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin | completed | Phase 1 | 5 | University of MinnesotaOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT01512407 | RCT on Adjuvant TACE After Hepatectomy for HCC(A-TECH) | completed | N/A | 58 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT01759901 | Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma | completed | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT02785835 | Hepatocellular Carcinoma in HIV-infected Patients(GEHEP-002) | completed | — | 477 | Hospital Universitario de ValmeOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT05281783 | RFA for Treatment of Intermediate Stage HCC | completed | N/A | 120 | Benha UniversityOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT04008082 | A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma | completed | — | 412 | Eisai Co., Ltd.INDUSTRY | 1 | Mar 8, 2022 | clinicaltrials |
| NCT04212286 | Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC | completed | N/A | 115 | Tianjin Third Central HospitalOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT02178358 | A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 132 | Eli Lilly and CompanyINDUSTRY | 5 | Feb 25, 2022 | clinicaltrials |
| NCT03884751 | Chimeric Antigen Receptor T Cells Targeting Glypican-3 | completed | Phase 1 | 9 | CARsgen Therapeutics Co., Ltd.INDUSTRY | 1 | Feb 24, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 | clinicaltrials |
| NCT04722120 | Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC | completed | N/A | 68 | Seoul National University HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT02392637 | Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers | completed | Phase 2 | 62 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT04811898 | A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment(LNA-i-miR221) | completed | Phase 1 | 17 | Azienda Ospedaliera Universitaria Mater Domini, CatanzaroOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT02947165 | Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. | completed | Phase 1 | 120 | Novartis PharmaceuticalsINDUSTRY | 9 | Jan 31, 2022 | clinicaltrials |
| NCT03490604 | Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients(ARABICA) | completed | — | 30 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT02837029 | Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer | completed | Phase 1 | 27 | Northwestern UniversityOTHER | 1 | Jan 25, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Jun 29, 2022source: clinicaltrials